Skip to main content

Table 2 Health state based utilities and costs used in the model

From: Improving access to antiretrovirals in China: economic analyses of dolutegravir in HIV-1 patients

Health states> 500350–500200–350100–20050–1000–50
Utilities0.8960.8990.8860.8610.8430.822
Costs (RMB)
 Outpatient care199823562356307248914891
 Inpatient care78710191017231791979075
 AOI2717188484201
 OI prophylaxis000112
 Cardiovascular event111417171717
 Indirect costs0327219127412741.274